These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 25794658)
81. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033 [TBL] [Abstract][Full Text] [Related]
82. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258 [TBL] [Abstract][Full Text] [Related]
83. Identification and management of adults with asthma prone to exacerbations: can we do better? Thomson NC; Chaudhuri R BMC Pulm Med; 2008 Dec; 8():27. PubMed ID: 19116019 [TBL] [Abstract][Full Text] [Related]
84. Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. Zhu R; Zheng Y; Putnam WS; Visich J; Eisner MD; Matthews JG; Rosen KE; D'Argenio DZ AAPS J; 2013 Apr; 15(2):559-70. PubMed ID: 23413101 [TBL] [Abstract][Full Text] [Related]
85. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. Zeiger RS; Schatz M; Zhang F; Crawford WW; Kaplan MS; Roth RM; Chen W J Allergy Clin Immunol; 2011 Aug; 128(2):412-4. PubMed ID: 21807253 [No Abstract] [Full Text] [Related]
86. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Petsky HL; Kynaston JA; Turner C; Li AM; Cates CJ; Lasserson TJ; Chang AB Cochrane Database Syst Rev; 2007 Apr; (2):CD005603. PubMed ID: 17443604 [TBL] [Abstract][Full Text] [Related]
87. Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma. Semprini R; Williams M; Semprini A; McDouall A; Fingleton J; Holweg C; Weatherall M; Beasley R; Braithwaite I J Allergy Clin Immunol Pract; 2018; 6(6):1982-1988.e1. PubMed ID: 29609049 [TBL] [Abstract][Full Text] [Related]
88. Susceptibility to exacerbations in Black adults with asthma. Grossman NL; Doros GD; Fandino N; Fuhlbrigge AL; Pace WD; Wechsler ME; Yawn BP; Israel E J Asthma; 2019 Jul; 56(7):704-710. PubMed ID: 29969928 [TBL] [Abstract][Full Text] [Related]
89. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Chipps BE; Zeiger RS; Borish L; Wenzel SE; Yegin A; Hayden ML; Miller DP; Bleecker ER; Simons FE; Szefler SJ; Weiss ST; Haselkorn T; J Allergy Clin Immunol; 2012 Aug; 130(2):332-42.e10. PubMed ID: 22694932 [TBL] [Abstract][Full Text] [Related]
90. Identifying the components of asthma health status in children with mild to moderate asthma. Holt EW; Cook EF; Covar RA; Spahn J; Fuhlbrigge AL J Allergy Clin Immunol; 2008 May; 121(5):1175-80. PubMed ID: 18466785 [TBL] [Abstract][Full Text] [Related]
92. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability. Murphy KR; Beuther DA; Chipps BE; Wise RA; McCann WA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Zeiger RS J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2092-2101.e4. PubMed ID: 38705273 [TBL] [Abstract][Full Text] [Related]
93. Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials. Grossman NL; Ortega VE; King TS; Bleecker ER; Ampleford EA; Bacharier LB; Cabana MD; Cardet JC; Carr TF; Castro M; Denlinger LC; Denson JL; Fandino N; Fitzpatrick AM; Hawkins GA; Holguin F; Krishnan JA; Lazarus SC; Nyenhuis SM; Phipatanakul W; Ramratnam SK; Wenzel S; Peters SP; Meyers DA; Wechsler ME; Israel E J Allergy Clin Immunol; 2019 Dec; 144(6):1524-1533. PubMed ID: 31520679 [TBL] [Abstract][Full Text] [Related]
94. Predictors of future exacerbations in a multi-ethnic Asian population with asthma. Tay TR; Wong HS; Tee A J Asthma; 2019 Apr; 56(4):380-387. PubMed ID: 29688092 [TBL] [Abstract][Full Text] [Related]
95. Risk factors for acute asthma in tropical America: a case-control study in the City of Esmeraldas, Ecuador. Ardura-Garcia C; Vaca M; Oviedo G; Sandoval C; Workman L; Schuyler AJ; Perzanowski MS; Platts-Mills TA; Cooper PJ Pediatr Allergy Immunol; 2015 Aug; 26(5):423-30. PubMed ID: 25955441 [TBL] [Abstract][Full Text] [Related]
96. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. Beuther DA; Murphy KR; Zeiger RS; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Chipps B J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3204-3212.e2. PubMed ID: 35998877 [TBL] [Abstract][Full Text] [Related]
97. Metformin use is associated with decreased asthma exacerbations in adolescents and young adults. Ararat E; Landes RD; Forno E; Tas E; Perry TT Pediatr Pulmonol; 2024 Jan; 59(1):48-54. PubMed ID: 37772681 [TBL] [Abstract][Full Text] [Related]